¼¼°èÀÇ Àΰø½ÉÆó±â ½ÃÀå ±Ô¸ð Á¶»ç ¹× ¿¹Ãø : ÄÄÆ÷³ÍÆ®º°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº° ºÐ¼®(2023-2030³â)
Global Heart-lung Machine Market Size study & Forecast, by Component, by Application (Coronary Artery Bypass Grafting, Heart Valve Surgeries, Heart Transplant, Lung Transplant, Others), by End Use, and Regional Analysis, 2023-2030
»óǰÄÚµå
:
1315011
¸®¼Ä¡»ç
:
Bizwit Research & Consulting LLP
¹ßÇàÀÏ
:
2023³â 07¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹®
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¼¼°èÀÇ Àΰø½ÉÆó±â ½ÃÀåÀº 2022³â¿¡ ¾à 21¾ï 8,000¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç, ¿¹Ãø ±â°£ÀÎ 2023-2030³â¿¡´Â 6.9% ÀÌ»óÀÇ °ÇÀüÇÑ ¼ºÀå·ü·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.
Àΰø½ÉÆó±â ½ÃÀåÀº Àΰø½ÉÆó±â·Î ¾Ë·ÁÁø ÀÇ·á±â±â¸¦ »ý»ê ¹× À¯ÅëÇÏ´Â »ê¾÷À¸·Î, °³½É¼ú½Ã ½ÉÀå°ú ÆóÀÇ ±â´ÉÀ» ÀϽÃÀûÀ¸·Î ´ë½ÅÇÏ¿© ȯÀÚÀÇ ½ÉÀåÀÌ ÀϽÃÀûÀ¸·Î Á¤ÁöµÈ µ¿¾È »ê¼Ò¸¦ ÇÔÀ¯ÇÑ Ç÷¾×À» Àü½Å¿¡ ¼øÈ¯½Ã۵µ·Ï °í¾ÈµÈ ÀåºñÀÔ´Ï´Ù. Àΰø½ÉÆó±â ½ÃÀåÀº ½ÉÇ÷°ü ¼ö¼ú Áõ°¡¿Í Àå±â ÀÌ½Ä Áõ°¡ µîÀÇ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù.
Àΰø½ÉÆó±â´Â Áß¿äÇÑ Àå±âÀÇ °ü·ù¸¦ À¯ÁöÇÏ°í ¼ö¼ú Áß È¯ÀÚÀÇ »ê¼Ò °ø±Þ°ú ¼øÈ¯À» ÀûÀýÈ÷ Áö¿øÇÔÀ¸·Î½á ¿Ü°ú Àǻ簡 º¹ÀâÇÑ ½ÉÀå ¼ö¼úÀ» ÇÒ ¼ö ÀÖµµ·Ï ÇÕ´Ï´Ù. ¹Ì±¹ ±¹¸³½ÉÆóÇ÷¾×¿¬±¸¼Ò(NIH)¿¡ µû¸£¸é ¼¼°è¿¡¼ ¸Å³â 200¸¸ ¸í ÀÌ»óÀÇ »ç¶÷µéÀÌ ´Ù¾çÇÑ ½ÉÀå °ü·Ã ÁúȯÀ» Ä¡·áÇϱâ À§ÇØ °³½É¼úÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ÀÌ¿Í ÇÔ²² ¹Ì±¹ÀÇ Àü±¹ Àå±â Á¶´Þ ¹× ÀÌ½Ä ³×Æ®¿öÅ©ÀÎ Àå±â³ª´®¿¬ÇÕ(UNOS)ÀÇ ¼Óº¸ µ¥ÀÌÅÍ¿¡ µû¸£¸é 2022³â¿¡´Â Àå±â ÀÌ½Ä °Ç¼ö°¡ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÃÑ Àå±â ÀÌ½Ä °Ç¼ö´Â 42,887°ÇÀ¸·Î Àü³âµµ 2021³â ´ëºñ 3.7%ÀÇ ´«¿¡ ¶ç´Â Áõ°¡¼¼¸¦ º¸¿´½À´Ï´Ù. ÀÌó·³ Àå±â ÀÌ½Ä °Ç¼ö Áõ°¡¿Í ½ÉÇ÷°ü ¼ö¼ú Áõ°¡°¡ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ Àΰø ½ÉÆó±âÀÇ ±â¼ú ¹ßÀü°ú °í·ÉÈ Àα¸ Áõ°¡´Â ½ÃÀå¿¡ À¯¸®ÇÑ ±âȸ¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª Àΰø½ÉÆó±â »ç¿ë¿¡ µû¸¥ ÇÕº´ÁõÀº 2023-2030³âÀÇ ¿¹Ãø ±â°£ Áß ½ÃÀå ¼ºÀå¿¡ °É¸²µ¹ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.
¼¼°èÀÇ Àΰø½ÉÆó±â ½ÃÀå Á¶»ç¿¡¼ °í·ÁÇÑ ÁÖ¿ä Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ & ¾ÆÇÁ¸®Ä«ÀÔ´Ï´Ù. ºÏ¹Ì´Â ½ÉÀ庴ÀÇ À¯º´·ü Áõ°¡, Á¤ºñµÈ ÇコÄɾî ÀÎÇÁ¶ó, ÀÌ Áö¿ª °í·ÉÈ¿¡ ÀÇÇØ 2022³â ½ÃÀåÀ» µ¶Á¡Çß½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ÇコÄɾî ÀÎÇÁ¶ó°¡ Á¤ºñµÇ°í Àα¸°¡ Áõ°¡Çϰí ÀÖÀ¸¹Ç·Î ¿¹Ãø ±â°£ Áß °¡Àå ±Þ¼ÓÈ÷ ¼ºÀåÇÏ´Â Áö¿ªÀ¸·Î °£Áֵǰí ÀÖ½À´Ï´Ù.
º» Á¶»çÀÇ ¸ñÀûÀº ÃÖ±ÙÀÇ ´Ù¾çÇÑ ºÎ¹®°ú ±¹°¡ÀÇ ½ÃÀå ±Ô¸ð¸¦ Á¤ÀÇÇϰí, ÇâÈÄ ¼ö³â°£ ½ÃÀå ±Ô¸ð¸¦ ¿¹ÃøÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ º¸°í¼´Â Á¶»ç ´ë»ó±¹¿¡¼ »ê¾÷ÀÇ ÁúÀû¡¤¾çÀû Ãø¸é ¾çÃøÀ» Æ÷ÇÔÇϵµ·Ï ¼³°èµÇ°í ÀÖ½À´Ï´Ù.
¶ÇÇÑ ½ÃÀåÀÇ ¹Ì·¡ ¼ºÀåÀ» ±ÔÁ¤ÇÏ´Â ÃËÁø¿äÀÎ ¹× °úÁ¦ µîÀÇ Áß¿äÇÑ Ãø¸é¿¡ °üÇÑ »ó¼¼ Á¤º¸µµ Á¦°øÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÁÖ¿ä ±â¾÷ÀÇ °æÀï ±¸µµ ¹× Á¦Ç° Á¦°øÀÇ »ó¼¼ ºÐ¼®°ú ÇÔ²² ÀÌÇØ°ü°èÀÚ°¡ ÅõÀÚÇϱâ À§ÇÑ ¹Ì½ÃÀû ½ÃÀåÀÇ ÀáÀçÀû ±âȸµµ Æ÷ÇÔÇϰí ÀÖ½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå ÁÖ¿ä ¿ä¾à
- ½ÃÀå ½º³À¼ô
- ¼¼°è ½ÃÀ塤ºÎ¹®º° ½ÃÀå Ã߻ꡤ¿¹Ãø, 2020-2030³â
- ÁÖ¿ä µ¿Çâ
- Á¶»ç ¹æ¹ý
- Á¶»ç ÀüÁ¦Á¶°Ç
Á¦2Àå ¼¼°èÀÇ Àΰø½ÉÆó±â ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
- Á¶»ç ¸ñÀû
- ½ÃÀåÀÇ Á¤ÀÇ¿Í ¹üÀ§
- Á¶»ç ´ë»ó³â
- ÅëÈ È¯»êÀ²
Á¦3Àå ¼¼°èÀÇ Àΰø½ÉÆó±â ½ÃÀå ¿ªÇÐ
- Àΰø½ÉÆó±â ½ÃÀåÀÇ ¿µÇ⠺м®(2020-2030³â)
- ½ÃÀå ÃËÁø¿äÀÎ
- ½ÉÀåÇ÷°ü ¼ö¼úÀÇ Áõ°¡
- Àå±â À̽ÄÀÇ Áõ°¡
- ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦
- Àΰø½ÉÆó±âÀÇ »ç¿ë¿¡ ¼ö¹ÝÇÏ´Â ÇÕº´Áõ
- ½ÃÀå ±âȸ
- Àΰø½ÉÆó±âÀÇ ±â¼ú Áøº¸
- °í·ÉÈ Àα¸ÀÇ Áõ°¡
Á¦4Àå ¼¼°èÀÇ Àΰø½ÉÆó±â ½ÃÀå »ê¾÷ ºÐ¼®
- Porter's 5 Force ¸ðµ¨
- °ø±Þ ±â¾÷ÀÇ ±³¼··Â
- ±¸¸ÅÀÚÀÇ ±³¼··Â
- ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
- ´ëüǰÀÇ À§Çù
- °æÀï ±â¾÷°£ °æÀï °ü°è
- Porter's 5 Force ¿µÇ⠺м®
- PEST ºÐ¼®
- Á¤Ä¡
- °æÁ¦
- »çȸ
- 񃬣
- ȯ°æ
- ¹ý·ü
- ÁÖ¿ä ÅõÀÚ ±âȸ
- ÁÖ¿ä ¼º°ø Àü·«
- COVID-19 ¿µÇ⠺м®
- ÆÄ±«Àû µ¿Çâ
- ¾÷°è Àü¹®°¡ÀÇ ½ÃÁ¡
- ¾Ö³Î¸®½ºÆ®ÀÇ °á·Ð¡¤Á¦¾È
Á¦5Àå ¼¼°èÀÇ Àΰø½ÉÆó±â ½ÃÀå : ÄÄÆ÷³ÍÆ®º°
- ½ÃÀå ½º³À¼ô
- ¼¼°èÀÇ Àΰø½ÉÆó±â ½ÃÀå : ÄÄÆ÷³ÍÆ®º°, ½ÇÀû - ÀáÀç·Â ºÐ¼®
- ¼¼°èÀÇ Àΰø½ÉÆó±â ½ÃÀå : ÄÄÆ÷³ÍÆ®º° ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
- ¼¼°èÀÇ Àΰø½ÉÆó±â ½ÃÀå : ÇÏÀ§ ºÎ¹®º° ºÐ¼®
- »ê¼Ò °ø±Þ±â
- ÆßÇÁ
- ij´¼¶ó
- ¸ð´ÏÅ͸µ ½Ã½ºÅÛ
- ¿±³È¯±â À¯´Ö
- Ç÷¾× ¸®Àú¹ö
- ±âŸ
Á¦6Àå ¼¼°èÀÇ Àΰø½ÉÆó±â ½ÃÀå : ¿ëµµº°
- ½ÃÀå ½º³À¼ô
- ¼¼°èÀÇ Àΰø½ÉÆó±â ½ÃÀå : ¿ëµµº°, ½ÇÀû - ÀáÀç·Â ºÐ¼®
- ¼¼°èÀÇ Àΰø½ÉÆó±â ½ÃÀå : ¿ëµµº° ÃßÁ¤¡¤¿¹Ãø 2020-2030³â
- Àΰø½ÉÆó±â ½ÃÀå : ÇÏÀ§ ºÎ¹®º° ºÐ¼®
- °ü»óµ¿¸Æ ¹ÙÀÌÆÐ½º¼ú(CABG)
- ½ÉÀåÆÇ¸· ¼ö¼ú
- ½ÉÀåÀ̽Ä
- ÆóÀ̽Ä
- ±âŸ
Á¦7Àå ¼¼°èÀÇ Àΰø½ÉÆó±â ½ÃÀå : ÃÖÁ¾ ¿ëµµº°
- ½ÃÀå ½º³À¼ô
- ¼¼°èÀÇ Àΰø½ÉÆó±â ½ÃÀå : ÃÖÁ¾ ¿ëµµº°, ½ÇÀû - ÀáÀç·Â ºÐ¼®
- ¼¼°èÀÇ Àΰø½ÉÆó±â ½ÃÀå : ÃÖÁ¾ ¿ëµµº° ÃßÁ¤¡¤¿¹Ãø 2020-2030³â
- ¼¼°èÀÇ Àΰø½ÉÆó±â ½ÃÀå : ÇÏÀ§ ºÎ¹®º° ºÐ¼®
Á¦8Àå ¼¼°èÀÇ Àΰø½ÉÆó±â ½ÃÀå : Áö¿ªº° ºÐ¼®
- ÁÖ¿ä ±¹°¡
- ÁÖ¿ä ½ÅÈï ±¹°¡
- Àΰø½ÉÆó±â ½ÃÀå : Áö¿ªº° ½ÃÀå ½º³À¼ô
- ºÏ¹ÌÀÇ Àΰø½ÉÆó±â ½ÃÀå
- ¹Ì±¹
- ÄÄÆ÷³ÍÆ® ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
- ¿ëµµº° ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
- ÃÖÁ¾ ¿ëµµ ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
- ij³ª´ÙÀÇ Àΰø½ÉÆó±â ½ÃÀå
- À¯·´ Àΰø½ÉÆó±â ½ÃÀå ½º³À¼ô
- ¿µ±¹ÀÇ Àΰø½ÉÆó±â ½ÃÀå
- µ¶ÀÏÀÇ Àΰø½ÉÆó±â ½ÃÀå
- ÇÁ¶û½ºÀΰø½ÉÆó±â ½ÃÀå
- ½ºÆäÀÎÀΰø½ÉÆó±â ½ÃÀå
- ÀÌÅ»¸®¾ÆÀÇ Àΰø½ÉÆó±â ½ÃÀå
- ±âŸ À¯·´ÀÇ Àΰø½ÉÆó±â ½ÃÀå
- ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Àΰø½ÉÆó±â ½ÃÀå ½º³À¼ô
- Áß±¹Àΰø½ÉÆó±â ½ÃÀå
- Àεµ Àΰø½ÉÆó±â ½ÃÀå
- ÀϺ»ÀÇ Àΰø½ÉÆó±â ½ÃÀå
- È£ÁÖ Àΰø½ÉÆó±â ½ÃÀå
- Çѱ¹ÀÇ Àΰø½ÉÆó±â ½ÃÀå
- ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Àΰø½ÉÆó±â ½ÃÀå
- ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ Àΰø½ÉÆó±â ½ÃÀå ½º³À¼ô
- ºê¶óÁúÀÇ Àΰø½ÉÆó±â ½ÃÀå
- ¸ß½ÃÄÚ Àΰø½ÉÆó±â ½ÃÀå
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« Àΰø½ÉÆó±â ½ÃÀå
- »ç¿ìµð¾Æ¶óºñ¾ÆÀÇ Àΰø½ÉÆó±â ½ÃÀå
- ³²¾ÆÇÁ¸®Ä«°øÈ±¹ÀÇ Àΰø½ÉÆó±â ½ÃÀå
- ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ Àΰø½ÉÆó±â ½ÃÀå
Á¦9Àå °æÀï Á¤º¸
- ÁÖ¿ä ±â¾÷ÀÇ SWOT ºÐ¼®
- ÁÖ¿ä ½ÃÀå Àü·«
- ±â¾÷ °³¿ä
- Terumo Europe NV
- ÁÖ¿ä Á¤º¸
- °³¿ä
- À繫(µ¥ÀÌÅÍÀÇ °¡¿ë¼º¿¡ µû¸§)
- Á¦Ç° °³¿ä
- ÃÖ±Ù µ¿Çâ
- LivaNova, Inc.
- Getinge Group
- Braile Biomedica
- NIPRO Pharma Corporation.
- Tianjin Welcome Medical Equipment Co., Ltd.
- ELITE LIFECARE
- Hemovent GmbH
- MERA(Senko Medical Instrument Mfg. Co., Ltd.)
- Technowood International Pte. Ltd.
Á¦10Àå Á¶»ç ÇÁ·Î¼¼½º
- Á¶»ç ÇÁ·Î¼¼½º
- µ¥ÀÌÅÍ ¸¶ÀÌ´×
- ºÐ¼®
- ½ÃÀå ÃßÁ¤
- °ËÁõ
- ÃâÆÇ
- Á¶»ç ¼Ó¼º
- Á¶»ç ÀüÁ¦
KSA
¿µ¹® ¸ñÂ÷
Global Heart-lung Machine Market is valued at approximately USD 2.18 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 6.9% over the forecast period 2023-2030. The heart-lung machine market pertains to the industry involved in the production and distribution of medical devices known as heart-lung machines, which are designed to temporarily take over the function of the heart and lungs during open-heart surgeries, facilitating the circulation of oxygenated blood throughout the body while the patient's heart is temporarily stopped. The Heart-lung Machine Market is being driven by factors such as the increasing number of cardiovascular surgeries and the increasing number of organ transplants.
The heart-lung machine allows surgeons to perform complex cardiac surgeries by maintaining vital organ perfusion and ensuring the patient's oxygenation and circulation are adequately supported during the procedure. According to the National Heart, Lung, and Blood Institute (NIH), more than 2 million people worldwide have open heart surgery each year to treat a range of heart-related conditions. Along with this, Preliminary data from the United Network for Organ Sharing (UNOS), the National Organ Procurement and Transplantation Network in the United States, indicates that in 2022, number of organ transplants were performed. The total number of organ transplants reached 42,887, representing a notable increase of 3.7 percent compared to the previous year 2021. Thus, the increasing number of organ transplants and increasing cardiovascular surgeries fuel the growth of the market. In addition to technology advancement in the heart-lung machine and the increasing aging population are creating lucrative opportunities for the market. However, the complications associated with the use of heart-lung machines may hinder the market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Heart-lung Machine Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the increasing prevalence of heart disease, well-developed healthcare infrastructure and aging population in the region. Asia Pacific is considered the fastest growing region during the forecasted period due to growing healthcare infrastructure and large population base.
Major market player included in this report are:
- Terumo Europe NV
- LivaNova, Inc.
- Getinge Group
- Braile Biomedica
- NIPRO Pharma Corporation.
- Tianjin Welcome Medical Equipment Co., Ltd.
- ELITE LIFECARE
- Hemovent GmbH
- MERA (Senko Medical Instrument Mfg. Co., Ltd.)
- Technowood International Pte. Ltd.
Recent Developments in the Market:
- In September 2022, LivaNova achieved a milestone with its Essenz heart-lung machine (HLM) receiving FDA 510(k) clearance, enabling the company to launch it commercially in the United States. This clearance follows previous approvals by Health Canada and the Japanese PMDA, highlighting LivaNova's global expansion efforts.
Global Heart-lung Machine Market Report Scope:
- Historical Data: 2020 - 2021
- Base Year for Estimatio: 2022
- Forecast period: 2023-2030
- Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
- Segments Covered: Component, Application, End Use, Region
- Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
- Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Component:
- Oxygenators
- Pumps
- Cannula
- Monitoring Systems
- Heat Exchanger Units
- Blood Reservoir
- Others
By Application:
- Coronary Artery Bypass Grafting (CABG)
- Heart Valve Surgeries
- Heart Transplant
- Lung Transplant
- Others
By End Use:
- Hospitals
- Cardiac Centers
- Others
By Region:
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- Spain
- Italy
- ROE
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- RoAPAC
- Latin America
- Brazil
- Mexico
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
Table of Contents
Chapter 1. Executive Summary
- 1.1. Market Snapshot
- 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
- 1.2.1. Heart-lung Machine Market, by Region, 2020-2030 (USD Billion)
- 1.2.2. Heart-lung Machine Market, by Component, 2020-2030 (USD Billion)
- 1.2.3. Heart-lung Machine Market, by Application, 2020-2030 (USD Billion)
- 1.2.4. Heart-lung Machine Market, by End Use, 2020-2030 (USD Billion)
- 1.3. Key Trends
- 1.4. Estimation Methodology
- 1.5. Research Assumption
Chapter 2. Global Heart-lung Machine Market Definition and Scope
- 2.1. Objective of the Study
- 2.2. Market Definition & Scope
- 2.2.1. Industry Evolution
- 2.2.2. Scope of the Study
- 2.3. Years Considered for the Study
- 2.4. Currency Conversion Rates
Chapter 3. Global Heart-lung Machine Market Dynamics
- 3.1. Heart-lung Machine Market Impact Analysis (2020-2030)
- 3.1.1. Market Drivers
- 3.1.1.1. Increasing Cardiovascular Surgeries
- 3.1.1.2. Increasing Number of Organ Transplants.
- 3.1.2. Market Challenges
- 3.1.2.1. Complications Associated with use of Heart-Lung Machines
- 3.1.3. Market Opportunities
- 3.1.3.1. Technology Advancement in Heart-Lung Machine
- 3.1.3.2. Increasing Aging Population
Chapter 4. Global Heart-lung Machine Market Industry Analysis
- 4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.2. Porter's 5 Force Impact Analysis
- 4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
- 4.4. Top investment opportunity
- 4.5. Top winning strategies
- 4.6. COVID-19 Impact Analysis
- 4.7. Disruptive Trends
- 4.8. Industry Expert Perspective
- 4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Heart-lung Machine Market, by Component
- 5.1. Market Snapshot
- 5.2. Global Heart-lung Machine Market by Component, Performance - Potential Analysis
- 5.3. Global Heart-lung Machine Market Estimates & Forecasts by Component 2020-2030 (USD Billion)
- 5.4. Heart-lung Machine Market , Sub Segment Analysis
- 5.4.1. Oxygenators
- 5.4.2. Pumps
- 5.4.3. Cannula
- 5.4.4. Monitoring Systems
- 5.4.5. Heat Exchanger Units
- 5.4.6. Blood Reservoir
- 5.4.7. Others
Chapter 6. Global Heart-lung Machine Market, by Application
- 6.1. Market Snapshot
- 6.2. Global Heart-lung Machine Market by Application, Performance - Potential Analysis
- 6.3. Global Heart-lung Machine Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
- 6.4. Heart-lung Machine Market , Sub Segment Analysis
- 6.4.1. Coronary Artery Bypass Grafting (CABG)
- 6.4.2. Heart Valve Surgeries
- 6.4.3. Heart Transplant
- 6.4.4. Lung Transplant
- 6.4.5. Others
Chapter 7. Global Heart-lung Machine Market, by End Use
- 7.1. Market Snapshot
- 7.2. Global Heart-lung Machine Market by End Use, Performance - Potential Analysis
- 7.3. Global Heart-lung Machine Market Estimates & Forecasts by End Use 2020-2030 (USD Billion)
- 7.4. Heart-lung Machine Market , Sub Segment Analysis
- 7.4.1. Hospitals
- 7.4.2. Cardiac Centers
- 7.4.3. Others
Chapter 8. Global Heart-lung Machine Market , Regional Analysis
- 8.1. Top Leading Countries
- 8.2. Top Emerging Countries
- 8.3. Heart-lung Machine Market , Regional Market Snapshot
- 8.4. North America Heart-lung Machine Market
- 8.4.1. U.S. Heart-lung Machine Market
- 8.4.1.1. Component breakdown estimates & forecasts, 2020-2030
- 8.4.1.2. Application breakdown estimates & forecasts, 2020-2030
- 8.4.1.3. End Use breakdown estimates & forecasts, 2020-2030
- 8.4.2. Canada Heart-lung Machine Market
- 8.5. Europe Heart-lung Machine Market Snapshot
- 8.5.1. U.K. Heart-lung Machine Market
- 8.5.2. Germany Heart-lung Machine Market
- 8.5.3. France Heart-lung Machine Market
- 8.5.4. Spain Heart-lung Machine Market
- 8.5.5. Italy Heart-lung Machine Market
- 8.5.6. Rest of Europe Heart-lung Machine Market
- 8.6. Asia-Pacific Heart-lung Machine Market Snapshot
- 8.6.1. China Heart-lung Machine Market
- 8.6.2. India Heart-lung Machine Market
- 8.6.3. Japan Heart-lung Machine Market
- 8.6.4. Australia Heart-lung Machine Market
- 8.6.5. South Korea Heart-lung Machine Market
- 8.6.6. Rest of Asia Pacific Heart-lung Machine Market
- 8.7. Latin America Heart-lung Machine Market Snapshot
- 8.7.1. Brazil Heart-lung Machine Market
- 8.7.2. Mexico Heart-lung Machine Market
- 8.8. Middle East & Africa Heart-lung Machine Market
- 8.8.1. Saudi Arabia Heart-lung Machine Market
- 8.8.2. South Africa Heart-lung Machine Market
- 8.8.3. Rest of Middle East & Africa Heart-lung Machine Market
Chapter 9. Competitive Intelligence
- 9.1. Key Company SWOT Analysis
- 9.1.1. Company 1
- 9.1.2. Company 2
- 9.1.3. Company 3
- 9.2. Top Market Strategies
- 9.3. Company Profiles
- 9.3.1. Terumo Europe NV
- 9.3.1.1. Key Information
- 9.3.1.2. Overview
- 9.3.1.3. Financial (Subject to Data Availability)
- 9.3.1.4. Product Summary
- 9.3.1.5. Recent Developments
- 9.3.2. LivaNova, Inc.
- 9.3.3. Getinge Group
- 9.3.4. Braile Biomedica
- 9.3.5. NIPRO Pharma Corporation.
- 9.3.6. Tianjin Welcome Medical Equipment Co., Ltd.
- 9.3.7. ELITE LIFECARE
- 9.3.8. Hemovent GmbH
- 9.3.9. MERA (Senko Medical Instrument Mfg. Co., Ltd.)
- 9.3.10. Technowood International Pte. Ltd.
Chapter 10. Research Process
- 10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
- 10.2. Research Attributes
- 10.3. Research Assumption
°ü·ÃÀÚ·á